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Background: We compared the continuous cardiac index measured by the FloTrac/VigileoTM system (FCI) to 
that measured by a pulmonary artery catheter (CCI) with emphasis on the accuracy of the FCI in patients with a 
decreased left ventricular ejection fraction (LVEF) and a low cardiac output status during off-pump coronary bypass 
surgery (OPCAB). We also assessed the influence of several factors affecting the pulse contour, such as the mean 
arterial pressure (MAP), the systemic vascular resistance index (SVRI) and the use of norepinephrine.
Methods: Fifty patients who were undergoing OPCAB (30 patients with a LVEF ≥ 40%, 20 patients with a LVEF < 40%) 
were enrolled. The FCI and CCI were measured and we performed a Bland-Altman analysis. Subgroup analyses were 
done according to the LVEF (< 40%), the CCI (≤  2.4 L/min/m), the MAP (60-80 mmHg), the SVRI (1,600-2,600 
dyne/s/cm5/m2) and the use of norepinephrine. 
Results: The FCI was reliable at all the time points of measurement with an overall bias and limit of agreement 
of -0.07 and 0.67 L/min/m2, respectively, resulting in a percentage error of 26.9%. The percentage errors in the 
patients with a decreased LVEF and in a low cardiac output status were 28.2% and 22.3%, respectively. However, the 
percentage error in the 91 data pairs outside the normal range of the SVRI was 40.2%.
Conclusions: The cardiac output measured by the FloTrac/VigileoTM system was reliable even in patients with a 
decreased LVEF and in a low cardiac output status during OPCAB. Acceptable agreement was also noted during the 
period of heart displacement and grafting of the obtuse marginalis branch. (Korean J Anesthesiol 2011; 60: 237-243)
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Introduction
    Estimating the cardiac output constitutes an essential part 
of the hemodynamic monitoring during cardiac surgery as 
it provides the basis for therapeutic interventions to ensure 
adequate tissue perfusion. For that purpose, a pulmonary 
artery catheter (PAC) using the thermodilution method has 
been considered a ‘clinical standard’ along with its attendant 
limitations [1]. The invasive nature of the PAC carries the risk of 
various complications, including damage to the cardiac valves 
and pulmonary artery rupture, and the clinical value of the data 
obtained from the PAC remains a matter of heated debate [2].
    The FloTrac/VigileoTM system (Edwards Lifesciences, Irvine, 
CA, USA) is a less invasive method of acquiring continuous 
data on the cardiac output and this system uses pulse contour 
analysis. It requires only standard radial artery catheterization 
and it empirically correlates the standard deviation (SD) of the 
pulse pressure to the stroke volume on the basis of the patient’s 
characteristics after automatic adjustment for actual vascular 
compliance and thus, it does not require external calibration [3]. 
    The earlier validation studies of the FloTrac/VigileoTM system 
have demonstrated conflicting results [4-7]. With the updated 
software (version 1.07) that provides a reduced time window 
(1 min) for vascular adjustment, the recent clinical studies that 
focused on cardiac surgeries have demonstrated promising 
results [8-10]. Still, the evidence regarding its accuracy is 
limited for surgeries accompanied with changes in the vascular 
compliance, and especially for patients with a decreased left 
ventricular ejection fraction (LVEF) and for patients with a low 
cardiac output status, and accurately estimating the cardiac 
output is of particular importance for clinical decision making. 
Furthermore, no comprehensive data exist regarding the 
influence of factors that affect the pulse contour. 
    We evaluated the accuracy of the cardiac output measured 
by the FloTrac/VigileoTM system (software version 1.07), as 
compared to the cardiac output measured by a PAC, in patients 
who are undergoing off-pump coronary bypass surgery 
(OPCAB), and we included patients with a decreased LVEF. We 
also evaluated the influence of the mean arterial pressure (MAP), 
the systemic vascular resistance index (SVRI) and the use of 
vasopressor on the performance of the FloTrac/VigileoTM system.
Materials and Methods
    This study was approved by the Institutional Review Board of 
our hospital and written informed consent was obtained from 
all subjects. The study subjects were 50 patients (30 patients 
with LVEF ≥ 40%, 20 patients with LVEF < 40%) who were 
scheduled for elective, isolated, multivessel OPCAB between 
June 2007 and February 2008. The LVEF was measured with 
transthoracic echocardiography and using the biplane modified 
Simpson’s method 1 day prior to surgery by cardiologists who 
were not aware of this study. The patients with preexisting 
pulmonary disease, concomitant valvular heart disease, cardiac 
arrhythmias and peripheral vascular disease were excluded 
from the study. 
    The patients’ cardiac medications were continued until the 
morning of the surgery, except for diuretics and antiplatelet 
agents. All the patients received 0.05-0.1 mg/kg of morphine 
intramuscularly as premedication 1 hr before their operation. 
Upon arrival at the operating room, standard monitoring 
devices were applied including a PAC (Swan-Ganz CCOmbo 
CCO/SvO2
TM, Edwards Lifesciences LLC, Irvine, CA, USA), 
which was inserted via the right internal jugular vein and 
connected to an analysis system (VigilanceTM, Edwards Life-
sciences LLC, Irvine, CA, USA) for continuous monitoring of the 
cardiac index (CCI) and the mixed venous oxygen saturation 
(SvO2). The radial artery was also cannulated in all the patients 
with a 20-G cannula (BD Angiocath PlusTM, Becton Dickinson 
Korea Ltd. Korea) and this was connected to a FloTrac/VigileoTM 
sensor for estimating the continuous arterial pressure waveform 
analysis cardiac index (FCI). All the transducers were zeroed 
at the mid-axillary level and care was taken to ensure that the 
pressure waveform was not dampened during the study period. 
Anesthesia was induced with intravenous midazolam (0.03-
0.07 mg/kg) and sufentanil (1.5-2.0 μg/kg), and anesthesia 
was maintained with sevoflurane (0.8-1.5%) and a continuous 
infusion of sufentanil (0.5-1.5 μg/kg/hr). Neuromuscular 
blockade was achieved by administering rocuronium (0.9 mg/
kg) and this was maintained with a continuous infusion of 
vecuronium (1-2 μg/kg/min). Isosorbide dinitrate 0.5 μg/kg/
min was infused in all the patients throughout the study period. 
The patients’ lungs were ventilated with a tidal volume of 8-10 
ml/kg, with an I : E ratio of 1 : 2, at a rate of 8-12 breaths/min of 
40% oxygen with air and a positive end-expiratory pressure of 5 
cmH2O during the surgery. Intravascular volume replacement 
was managed with crystalloid and colloid solutions to maintain 
the pulmonary capillary wedge pressure between 8-16 mmHg 
according to the baseline values prior to manipulation of the 
heart and after completion of grafting. During the period of 
heart displacement, the crystalloid solution was infused at a 
fixed rate of 6-8 ml/kg/hr, whereas the colloid solution was 
infused to compensate for the amount of blood loss collected 
by a cell salvage device. The blood salvaged by the cell salvage 
device was reinfused to the patient before the end of the surgery. 
The hemodynamic management was as follows; 1) maintenance 
of the MAP between 60-80 mmHg with either a norepinephrine 
or nicardipine infusion with a 10-20o Trendelenburg position 
and/or a norepinephrine infusion during heart displacement), 2) 
infusion of milrinone in the patients with a SvO2 < 60% for longer 
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than 10 min and/or the development of mitral regurgitation ≥ 
grade 3 with a concomitant rise of the mean pulmonary arterial 
pressure > 30 mmHg. Allogenic packed red blood cells were 
transfused when the hematocrit level was < 25% throughout 
the study period. The central temperature, as measured by the 
PAC, was maintained between 36-37oC with a warm mattress, a 
forced warm air blanket and fluid warmer as necessary.
    All the surgical procedures were performed by one surgeon 
through a median sternotomy and the heart was displaced 
using posterior pericardial stitches, large (12 × 70 cm) gauze 
swabs and tissue stabilizer (Octopus Tissue Stabilization 
SystemⓇ, Medtronic Inc. USA). All the patients were transferred 
to the intensive care unit after the surgery.
    The hemodynamic variables obtained from the PAC and 
FloTrac/VigileoTM system, including the CCI, FCI, SvO2, heart 
rate (HR), central venous pressure (CVP) and SVRI, were 
recorded at the following time points: 15 min after induction 
of anesthesia (baseline, T1), during Y-graft construction with 
the opened pericardium and the heart in a neutral position 
(T2), 5 min after stabilizer application for the obtuse marginalis 
branch anastomosis (T3), 15 min after completion of grafting 
with the opened pericardium (T4) and 15 min after sternum 
closure (T5). At T3, the average of 3 consecutive STAT mode 
cardiac index measurements by the PAC was considered as the 
CCI and the average of 3 consecutive 20 sec trend cardiac index 
measurements by the FloTrac/VigileoTM system was considered 
as the FCI. Of the 3 consecutive measurements by both the 
PAC and the FloTrac/VigileoTM system, the middle values were 
acquired at 5 min after applying stabilizer to coincide with the 
timing of the cardiac output measurement. At the other time 
points of measurements, the trend for the FCI was set to 5 min. 
The SVRI was calculated with the CCI.
    Statistical analyses were performed using SPSS 12.0 (SPSS 
Inc., Chicago, IL, USA). All the data is expressed as the number 
of patients or means ± SDs. The data was assessed for a normal 
distribution of variance with the Shapiro-Wilk test. Repeated 
measurements of ANOVA with the Bonferroni test was used 
to compare the hemodynamic variables between consecutive 
measurements. The FCI and CCI were compared using a 
modified Bland-Altman analysis of agreement for repeated 
measures, where bias was defined as the average difference 
between the FCI and CCI values and the limit of agreement was 
defined as the 2 SDs of the bias [11,12]. The percentage error (2 
SDs of the bias/mean cardiac index) was calculated according 
to Critchley and Critchley [13]. A percentage error of 30% or less 
was esta blished as the criterion for method interchangeability 
[13]. Subgroup analyses that compared the FCI and CCI with 
the same stati stical methods were performed according 
to a LVEF < 40%, and without modification for repeated 
measures according to a CCI ≤ 2.4 L/min/m2, a MAP of 60-80 
mmHg, a SVRI of 1,600-2,600 dyne s/cm5/m2 and the use of 
norepinephrine.
Results
    OPCAB could be successfully performed in all 50 patients and 
a total of 250 data pairs could all be recorded and then analyzed. 
Table 1. Patients’ Characteristics          
Variables Value
Age (yr)
Gender (male/female)
Body surface area (m2)
LVEF (%)
Diabetes mellitus (DM)
Hypertension (HTN)
DM + HTN
Preoperative cardiac medication
    Nitrate
    Beta blocker
    Calcium channel blocker
    RAS blocker
64 (47-77)
38/22
1.8 ± 0.2
49 ± 16
23
30
14
11
24
23
26
Values are medians (range), means (SD) or number of patients. RAS 
blocker: rennin-angiotensin system antagonist.
Table 2. Hemodynamic Data 
T1 T2 T3 T4 T5
HR (beats / min)
MAP (mmHg)
CVP (mmHg)
SvO2 (%)
CCI (L/min/m2)
FCI (L/min/m2)
SVRI (dyne s/cm5/m2)
60 ± 9
73 ± 10
7 ± 2
78 ± 6
2.8 ± 0.6
2.6 ± 0.4
1,956 ± 549
62 ± 10
73 ± 7
7 ± 2
76 ± 6
2.7 ± 0.4
2.6 ± 0.4
1,925 ± 382
64 ± 9
76 ± 9
9 ± 3*
68 ± 8*
2.1 ± 0.3*
2.2 ± 0.3*
2,464 ± 469*
64 ± 9
73 ± 7
8 ± 3
74 ± 8
2.6 ± 0.5
2.5 ± 0.5
2,361 ± 526
66 ± 9*
76 ± 7
7 ± 3
76 ± 7
2.6 ± 0.5
2.6 ± 0.4
2,264 ± 543
The table presents the hemodynamic data. The data is presented as means ± SDs. T1: 15 min after induction of anesthesia, T2: during Y-graft 
construction with opened pericardium, T3: 5 min after applying stabilizer for creating an obtuse marginalis branch anastomosis, T4: 15 min 
after completion of grafting with opened pericardium, T5: 15 min after sternum closure, HR: heart rate, MAP: mean arterial pressure, CVP: 
central venous pressure, SvO2: mixed venous oxygen saturation, CCI: continuous cardiac index measured by a pulmonary artery catheter, FCI: 
cardiac index measured by the FloTrac/VigileoTM system, SVRI: systemic vascular resistance index. *P < 0.05 compared to the values at T1.
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The patients’ characteristics are listed in Table 1. All the patients 
were in normal sinus rhythm throughout the study period.
    The hemodynamic data is listed in Table 2. The CVP and SVRI 
were significantly increased, and the SvO2, CCI and FCI were all 
significantly decreased at T3 compared to each baseline value.
    Overall, the CCI and FCI values were 2.7 ± 0.5 L/min/m2 (range: 
1.4-4.5) and 2.6 ± 0.4 L/min/m2 (range: 1.6-4.1), respectively. 
Bland-Altman analysis of the FCI and CCI values demonstrated 
an overall mean bias and a limit of agreement of -0.07 and 0.67 
L/min/m2, respectively, resulting in a percentage error of 26.9%. 
The bias, limit of agreement and percentage error at various 
predefined time points of measurement were all acceptable. 
(Table 3, Fig. 1).
    The results of the subgroup analyses according to the LVEF, 
CCI, MAP, SVRI and norepinephrine use are listed in Table 4 
and Fig 1. The data pairs of the patients with a decreased LVEF 
(< 40%) or CCI ≤ 2.4 L/min/m2 all demonstrated a percentage 
error of < 30%. The data pairs divided according to a MAP of 
60-80 mmHg and norepinephrine use also demonstrated a 
percentage error of < 30%. However, the data pairs of a SVRI 
of either < 1,600 or > 2,600 dyne s/cm5/m2 demonstrated a 
percentage error of 40.2% in contrast to the percentage error of 
15.5% for the data pairs of a SVRI between 1,600 and 2,600 dyne 
s/cm5/m2.
Fig. 1. Modified Bland-Altman analysis for repeated measures of 
agree ment between the continuous cardiac index as measured 
by the FloTrac/VigileoTM system (FCI) and a pulmonary artery 
catheter (CCI). (A) Overall, 250 data pairs, (B) 20 patients with a left 
ventricular ejection fraction < 40%, 100 data pairs, (C) 30 patients 
with left ventricular ejection fraction ≥ 40%, 150 data pairs. The 
unit of bias and the limit of agreement are L/min/m2.
Table 3. Bland-Altman Analyses of the Cardiac Index 
T1 T2 T3 T4 T5 Total
Bias (L/min/m2)
Limit of agreement (L/min/m2)
% error
-0.23
0.78
28.9
-0.12
0.52
19.6
0.10
0.56
26.4
-0.05
0.60
23.5
-0.08
0.60
24.1
-0.07
0.67
26.9
The table presents the Bland-Altman analyses of the cardiac index as measured by the FloTrac/VigileoTM system and the pulmonary artery 
catheter. T1: 15 min after induction of anesthesia, T2: during Y-graft construction with opened pericardium, T3: 5 min after applying stabilizer 
for creating an obtuse marginalis branch anastomosis, T4: 15 min after completion of grafting with opened pericardium, T5: 15 min after 
sternum closure.
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    None of the patients required a nicardipine or milrinone 
infusion during the study period.
Discussion
    This prospective trial evaluated the accuracy of the FloTrac/
VigileoTM system-derived cardiac output in patients who 
were undergoing OPCAB, and we found clinically acceptable 
agreement between the FCI and CCI and even for the patients 
with a decreased LVEF or a low cardiac output status. The 
agreement was acceptable regardless of the MAP or the use of 
norepinephrine, except that the agreement was unacceptable 
(40.2%) when the SVRI was out of the normal range.
    Accurate determining the cardiac output constitutes an 
important axis of hemodynamic monitoring by providing 
the basis for guiding therapy to ensure adequate tissue 
perfusion, and especially in cardiac surgical patients. While 
the thermodilution method using the PAC with its attendant 
limitations is currently considered as a clinical standard, less 
invasive methods using arterial pressure waveform analysis 
are being extensively studied for their clinical feasibility [3-
10,14-17]. Among them, the FloTrac/VigileoTM system is the 
least invasive method because it does not require central 
venous access for external calibration to compensate for the 
interindividual differences in aortic compliance [3]. The SD 
of the pulse pressure is correlated to the stroke volume after 
adjustment for vascular compliance, which is estimated 
using the individual demographic data and the wave form 
characteristics such as skewness and kurtosis. Therefore, the 
operator dependency is minimized and the drift phenomena 
may be eliminated by automatic adjustment for the changes in 
the vascular tone. Yet the benefit of being less invasive provides 
a potential source to increased bias, and so this decreases 
the accuracy of the measured cardiac output. Indeed, earlier 
validation studies have demonstrated conflicting results 
with acceptable accuracy observed mostly in patients with 
hemodynamically stable conditions [4-7].
    With the improved algorithm of the FloTrac/VigileoTM system 
(software version 1.07), the rate of adjustment of the internal 
variables for estimating the vascular tone is reduced from 10 to 1 
minutes combined with a reduction of the pulse wave detection 
noise. Validation studies of this second generation device have 
demonstrated more consistent results in cardiac surgeries with 
good agreement for the OPCAB and cardiac surgeries that are 
done under cardiopulmonary bypass as well [8-10]. However, 
none of the previous studies used a modified Bland-Altman 
analysis of agreement for repeated measures, and the cardiac 
output in the previous studies was measured and compared 
at multiple time points from each patient. Moreover, the 
previously reported evidence is limited regarding the accuracy 
of the cardiac output, as measured by the FloTrac/VigileoTM 
system, in patients with a decreased LVEF and in those patients 
with a lower than normal or low cardiac output status, which 
is when accurate estimation of the cardiac output is especially 
required to decide whether therapies targeted to improve 
oxygen delivery should be initiated. Moreover, considering 
that the peripheral arterial pulse wave is the summation of 
the reflected waves with the fundamental waves determined 
by the interaction between the left ventricular output and 
the capacitance of the vascular tree [18], abnormal ranges of 
the MAP and SVRI and the use of vasopressors could all be 
potential sources of error in the pulse contour analysis-derived 
cardiac output measurement. Yet no comprehensive data exist 
regarding the influence of these factors on the accuracy of the 
cardiac output measured by the FloTrac/VigileoTM system.
    The results of this current trial indicate that the cardiac 
output measured by the FloTrac/VigileoTM system consistently 
demonstrated good agreement with a percentage error ≤ 30% 
Table 4. Subgroup Bland-Altman Analyses of the Cardiac Index 
FCI CCI Bias Limit of agreement % error
LVEF
CCI
MAP
SVRI
NE
≥ 40 (n = 150)
< 40 (n = 100)
> 2.4 (n = 135)
≤ 2.4 (n = 115)
60-80 (n = 207)
< 60 or > 80 (n = 43)
1,600-2,600 (n = 159)
<1,600 or > 2,600 (n = 91)
Not used (n = 137)
Used (n = 113)
2.6 ± 0.4
2.4 ± 0.4
2.7 ± 0.4
2.2 ± 0.3
2.4 ± 0.4
2.7 ± 0.5
2.5 ± 0.4
2.5 ± 0.5
2.5 ± 0.4
2.4 ± 0.5
2.7 ± 0.5
2.5 ± 0.4
2.9 ± 0.4
2.2 ± 0.2
2.6 ± 0.5
2.5 ± 0.5
2.5 ± 0.3
2.6 ± 0.7
2.6 ± 0.5
2.5 ± 0.5
-0.05
-0.09
-0.19
0.08
-0.12
0.14
-0.06
-0.09
-0.11
-0.03
0.66
0.67
0.70
0.48
0.61
0.77
0.38
1.01
0.71
0.61
25.2
28.2
25.3
22.3
24.8
30.0
15.5
40.2
27.8
25.3
The table presents the subgroup Bland-Altman analyses of the cardiac index as measured by the FloTrac/VigileoTM system (FCI, L/min/m2) and 
the pulmonary artery catheter (CCI, L/min/m2) according to the left ventricular ejection fraction (LVEF, %), the CCI, the mean arterial pressure 
(MAP, mmHg), the systemic vascular resistance index (SVRI, dyne·s/cm5/m2) and the use of norepinephrine (NE). n corresponds to the number 
of obtained data sets. FCI and CCI are presented as means ± SDs. The unit of bias and the limit of agreement are L/min/m2. 
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at various time points of measurements during OPCAB. Good 
agreement could also be demonstrated in the patients with a 
decreased LVEF (< 40%) and at time points of a decreased CCI 
(≤ 2.4 L/min/m2), including the period of heart displacement 
for obtuse marginalis artery grafting when the hemodynamic 
derangement is most severe [19]. This seems to be attributable 
to the improved algorithm of the FloTrac/VigileoTM system that 
attenuates the bias induced by the hemodynamic changes that 
accompany various surgical situations such as sternotomy, 
opened pericardium, heart displacement and cumulative 
ischemia-reperfusion injury of various degrees.
    It is interesting to note was that the FloTrac/VigileoTM system 
performed well regardless of the range of the MAP or the use 
of vasopressor. However, in contrast to the best agreement 
(percentage error: 15.5%) demonstrated when the SVRI was 
within the normal range, the accuracy of the cardiac output 
measured by the FloTrac/VigileoTM system was poor with 
unacceptable agreement (percentage error: 40.2%) when the 
SVRI was outside the normal range. Unacceptable agreement 
had previously been demonstrated in a study of patients with 
liver cirrhosis and who were undergoing liver transplantation 
with a low SVRI [20]. FCI has also been demonstrated 
to be unreliable when phenylephrine was administered 
[21,22]. However, in those previous studies, phenylephrine 
administration increased the MAP to 82-90 mmHg, while the 
mean MAP could be maintained between 73-76 mmHg in the 
current study. Although the SVRI was not calculated in both of 
the previous studies, an increase in the MAP in our study was 
accompanied by a decrease in the CCI, suggesting a significant 
increase in afterload and thus the SVRI over the normal range. 
It seems that the extent of vasodilation or vasoconstriction, 
as manifested by extreme ranges of the SVRI, has the most 
influential impact on the arterial pressure waveform [23], 
regardless of the MAP or the use of vasopressor. Yet it is difficult 
to compare and state that this poor performance for a SVRI 
outside the normal range is a consistent finding since the data 
regarding this matter is limited at best. In order to improve the 
device’s performance, this issue should also be addressed and 
incorporated when developing a more refined algorithm for the 
FloTrac/VigileoTM system.
    In this study, the FCI was compared to the CCI and not with 
the cardiac index measured by intermittent PAC thermodilution, 
which could be a limitation. However, numerous studies have 
validated the accuracy of the CCI as compared to intermittent 
PAC thermodilution and even to electromagnetic measurement 
of the aortic blood flow, which is considered the ‘gold standard’ 
in cardiac laboratories [24,25]. Moreover, one of the benefits 
of the FloTrac/VigileoTM system is the minimized operator 
dependency, which is not the case for the intermittent PAC 
thermodilution method. Indeed, the variation between two 
series of three intermittent thermodilution cardiac output 
measurements is still as high as 15%, and in that regard the CCI 
has better reproducibility with negligible bias and so it is the less 
operator-dependent method [26]. The CCI value is an average 
made over 3-8 minutes of time and when the trend of the 
FloTrac/VigileoTM system is set to 5 minutes, it would be more 
ideal to compare the FCI to the CCI rather than comparing the 
FCI to the cardiac output as measured by the intermittent PAC 
thermodilution method. Likewise, since the response time of 
the STAT mode of the PAC to changes in the cardiac output has 
been demonstrated to be approximately 270 seconds [27], we 
used the STAT mode at T3 to minimize a potential source of 
error.
    In conclusion, the cardiac output measured by the FloTrac/
VigileoTM system was reliable even in patients with a decreased 
LVEF and who were in low cardiac output status during 
OPCAB. The modified algorithm appears to be robust in 
various situations of hemodynamic changes such as during the 
period of heart displacement and also regardless of the use of 
vasopressor. However, additional refinement of the algorithm 
should be done to improve the reliability when the SVRI is 
outside the normal range. 
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